Stopping Surveillance for Low-Risk Barrett's Esophagus
Part of Cancer, Digestive system clinical trials.
This study is testing whether it's safe to stop regular surveillance endoscopies for people with low-risk Barrett's esophagus. If you have a short Barrett's segment without any dysplasia, you may be able to avoid future procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Barrett's esophagus without any dysplasia (abnormal cells).
- Your Barrett's segment is less than 5 cm (about 2 inches) long.
- You are between 55 and 75 years old.
- You have not had any low-grade dysplasia or indefinite for dysplasia in the last 2 years or on your most recent endoscopy.
- No family history of esophageal or stomach cardia cancer in a parent, sibling, or child.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new risk model to predict if early Barrett's esophagus-related cancer may return. It also looks at how telling patients their risk affects their quality of life and fear of cancer. If you have Barrett's with a small, early cancer, this study may help decide the best follow-up plan for you.
This study compares two ways of taking tissue samples during endoscopy to check how Barrett’s esophagus is changing. The goal is to improve surveillance, especially for finding early precancer or early cancer changes.
This trial tests if a capsule-sponge device can replace endoscopy for monitoring people with ultralong-segment Barrett's esophagus. It aims to make surveillance easier and less invasive.
This trial compares two approaches for people with Barrett’s esophagus and low-grade dysplasia: regular monitoring versus treatment done through an endoscopy. It aims to see which approach is safer and better at preventing progression to more serious changes in the esophagus.
This trial tests a device that collects cells from the esophagus using a swallowed capsule, which may detect Barrett's esophagus without a standard endoscopy. It is for people who are already scheduled for an endoscopy.
This trial tests two simple, non-surgical methods to look for Barrett's esophagus (a change in the lining of the swallowing tube) and early esophageal cancer. It is for people who are at higher risk or lower risk, but have never had Barrett's or cancer before.
Hear when a new Barrett Esophagus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.